Tag: SII

Serum Institute of India (SII) is confident of getting approval for Covishield from European Medicines Agency (EMA) within a month. SII’s CEO Adar Poonawalla also said that the issue of ...

Pune: The Serum Institute of India (SII) announced on Friday that his company has manufactured the first batch of the Covavax COVID-19 vaccine, which has been developed by US-based biotechnology ...

New Delhi: Serum Institute of India (SII) is expected to begin clinical trials of Novavax’s COVID-19 vaccine ‘Covovax’ for children this July, according to media reports. SII is also planning ...

New Delhi: Covishield-maker Serum Institute of India (SII) has sought indemnity from liability or legal protection from any claims linked any severe side effects from the company’s COVID-19 vaccine. Notably, ...

New Delhi: Executive Director of Pune-based Serum Institute of India (SII) Suresh Jadhav on Friday alleged that the government began inoculating people from multiple age groups without taking into account ...

New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said vaccines were never exported at the cost of people of India, adding that there were commitments to ...

Pune: The Serum Institute of India (SII) on Saturday said that only a limited portion of its volume of Covidshield will be sold to private hospitals at Rs 600 per ...

New Delhi: COVID-19 vaccine manufacturers Bharat Biotech and Serum Institute of India (SII) will get Rs 1,500 crore and Rs 3,000 crore each as supply credit from the Finance Ministry. ...

Pune: The Serum Institute of India (SII) has fully refunded South Africa for the 500,000 doses of the COVID-19 vaccine, which were not delivered to the country after it decided ...

New Delhi: The Serum Institute of India (SII) has geared up to raise the output of Covishield vaccines by 67% to 100 million doses a month from May. The move ...